RESEARCH SUMMARY -Latest Outcome of Our Research-
02/24/09
Research Findings on Bio Venture Companies 2008
-Urgently required to secure R&D funds: Trend for growth to start in 2012-
Research Outline
Yano Research Institute has conducted a study on the bio venture companies as described below.
1. Research period: July to December 2008
2. Research targets: Domestic bio venture companies, related enterprises and organizations
3. Research methodologies:
Face-to-face interviews with relevant personnel, supplemented by interviews via telephone and e-mail, and literature researches.
<What is Bio Venture Company?>
In this research, a bio venture company is defined as an enterprise founded in and after 1985, and focused on the research and development of bio related technologies.
2. Research targets: Domestic bio venture companies, related enterprises and organizations
3. Research methodologies:
Face-to-face interviews with relevant personnel, supplemented by interviews via telephone and e-mail, and literature researches.
<What is Bio Venture Company?>
In this research, a bio venture company is defined as an enterprise founded in and after 1985, and focused on the research and development of bio related technologies.
Summary of Research Findings
¨ In the worsening investment conditions, the selection of enterprises is progressing, making it a challenge to secure operational funds and human resources.
As business confidence worsens in Japan, investors have turned to avoiding risks and started to withdraw their investment funds in the bio venture industry, causing the shortage of research and development funds, and the progress of shakeout in the market. According to the questionnaire survey conducted in relation with this research, financing and human resource are two of the most urgent management issues.
As business confidence worsens in Japan, investors have turned to avoiding risks and started to withdraw their investment funds in the bio venture industry, causing the shortage of research and development funds, and the progress of shakeout in the market. According to the questionnaire survey conducted in relation with this research, financing and human resource are two of the most urgent management issues.
¨ Short-term forecast indicates “Growth Trend” with rapid growth in “Drag Discovery”
In a short-term forecast (as of 2012), many enterprises expect their major business segments to “grow”, especially rapid growth in “drug discovery” (research and development of new drugs). On the other hand, they expect the business to decrease in “extracorporeal diagnostic agents” (research and development of clinical diagnostic agents)
¨ In the future, the market will be driven by leading bio ventures with outstanding technologies and solid business plans.
Although the tough situation may continue, successful enterprises partnered with domestic or overseas major private businesses are beginning to be observed, such as a bio venture, having high technological capability as well as a competent business model, who has achieved a large-scale alliance with a leading pharmaceutical company. In the future these highly competent bio ventures will lead and drive the industry.
Published Report
Report Title: Bio Venture Companies 2009
*The information provided in the "Research Summary" is what is as of the date of announcement and could be altered or renewed without any prior notice.
